BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/27/2025 7:04:45 AM | Browse: 1 | Download: 6
 |
Received |
|
2025-01-11 13:41 |
|
Peer-Review Started |
|
2025-01-21 09:21 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-02-19 07:10 |
|
Revised |
|
2025-02-27 16:15 |
|
Second Decision |
|
2025-03-24 02:39 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-03-24 08:59 |
|
Articles in Press |
|
2025-03-24 08:59 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-05-14 08:25 |
|
Publish the Manuscript Online |
|
2025-05-27 07:04 |
| ISSN |
1948-5182 (online) |
| Open Access |
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Open questions on how metabolic dysfunction-associated steatotic liver disease shapes the course of drug-induced liver injury
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Mariana M Ramírez-Mejía, Rolf Teschke and Nahum Méndez-Sánchez |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Nahum Méndez-Sánchez, MD, PhD, Professor, Liver Research Unit, Medica Sur Clinic & Foundation, 150 Puente de Piedra, Mexico City 14050, Mexico. nmendez@medicasur.org.mx |
| Key Words |
Metabolic dysfunction-associated steatotic liver disease; Drug-induced liver injury; Metabolic dysfunction; Hepatotoxicity; Roussel Uclaf Causality Assessment Method; Immune response |
| Core Tip |
This article reviews the study by Zhao et al on the interaction between metabolic dysfunction-associated steatotic liver disease and drug-induced liver injury. This study highlights distinct clinical patterns in patients with metabolic dysfunction-associated steatotic liver disease and drug-induced liver injury, such as metabolic dysregulation (elevated triglycerides, cholesterol and insulin) and immune activation (increased levels of interleukin-4 and complement C3). The use of the updated Roussel Uclaf Causality Assessment Method strengthens the assessment of causality, emphasizing the need for tailored diagnostic approaches and therapeutic strategies. This work paves the way for prospective studies and biomarker discovery to improve patient outcomes at the intersection of these conditions. |
| Publish Date |
2025-05-27 07:04 |
| Citation |
<p>Ramírez-Mejía MM, Teschke R, Méndez-Sánchez N. Open questions on how metabolic dysfunction-associated steatotic liver disease shapes the course of drug-induced liver injury. <i>World J Hepatol</i> 2025; 17(5): 105072</p> |
| URL |
https://www.wjgnet.com/1948-5182/full/v17/i5/105072.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v17.i5.105072 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
